Teradyne (TER +12.12%) The stock price soared more than 15% as of 2pm today as the market took a more positive look at the company’s first quarter 2026 earnings report released on Tuesday. This is an attractive situation for investors focused on artificial intelligence (AI). Teradyne CEO Gregory Smith said on an earnings call that AI is “a dominant force shaping our business” and “represents nearly 70% of our revenue, up from approximately 60% in the fourth quarter of 2025.”
Teradyne and AI semiconductor cycle
The company manufactures automated test equipment systems that evaluate the functional capabilities of chips. as A.I. As chips become increasingly complex and important to the global economy, and investment in AI continues to boom, Teradyne continues to experience exceptional growth. The company posted a strong first-quarter sales increase of 87% year over year, but its stock fell on Tuesday after management’s second-quarter guidance disappointed investors.
Today’s changes
(12.12%) $37.14
current price
$343.47
Key data points
Market capitalization
$48 billion
daily range
$326.73 -$353.54
52 week range
$73.11 -$422.11
volume
7.8M
average volume
3.7M
gross profit
58.64%
dividend yield
0.16%
Revenue guidance of $1.15 billion to $1.25 billion represents an increase of 76% to 92% It also means a gradual decline from $1.28 billion through the second quarter of 2025. Recently reported in the first quarter. That was enough significantly lower stock pricesThis could also be bad news for AI investors, as the market quickly began pricing in an inflection point in the company’s earnings trajectory.
Why stock prices recovered today
Management argued that the implied sequential decline in revenue reflected more natural irregularities in the timing of orders than fundamental changes in the market. The company also claimed that its vertically integrated producer (VIP) computing has been “extremely strong in the first half of this year,” but that next-generation technology will arrive “early” in 2027, leaving demand uncertain in the second half of 2026.
Image source: Getty Images.
Analysts from two of Wall Street’s leading firms, Goldman Sachs and JPMorgan, agreed with one of the former’s analysts and raised their price target from $300 to $350 while maintaining a buy rating, while one of the latter’s analysts upgraded the stock from neutral to overweight while maintaining a $400 price target.
Lee Samaha has no position in any stocks mentioned. The Motley Fool recommends Teradyne. The Motley Fool has a disclosure policy.
